Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Akorn, Inc.: Phenylephrine Hydrochloride Ophthalmic Solution Recalled for Sterility Issues

Agency Publication Date: September 30, 2019
Share:
Sign in to monitor this recall

Summary

Approximately 60,176 bottles of Phenylephrine Hydrochloride Ophthalmic Solution (USP, 2.5%, 15 mL), a prescription medication used for eye exams and procedures, have been recalled. The product failed testing intended to ensure the container remains sealed and sterile, meaning the sterility of the drops cannot be guaranteed. This recall affects one specific lot of bottles distributed nationwide in the USA and Puerto Rico. Consumers should stop using the affected lot immediately to avoid potential contamination risks.

Risk

A failure in the container's closure system means that the medicine may not remain sterile and could become contaminated with microorganisms. Using non-sterile eye drops can lead to serious eye infections, which in some cases may result in permanent vision damage.

What You Should Do

  1. Check your prescription eye drop bottles for the product name 'Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5%' in a 15 mL size.
  2. Verify the identification details on the label: look for NDC 17478-201-15 and specifically check for Lot Number 031908A with an expiration date of 03/20.
  3. If you identify a bottle matching these specific lot and expiration details, stop using the medication immediately.
  4. Contact your healthcare provider or pharmacist for guidance on obtaining a replacement and to discuss any concerns regarding your eye health.
  5. Return any unused product to your pharmacy for a refund and contact Akorn, Inc. for further instructions regarding the disposal or return of the medication.
  6. For additional questions or to report a problem, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare provider consultation and pharmacy refund.

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Phenylephrine Hydrochloride Ophthalmic Solution, USP, 2.5% (15 mL bottle)
Model:
NDC 17478-201-15
Recall #: D-1883-2019
Lot Numbers:
031908A (Exp 03/20)

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 83843
Status: Resolved
Manufacturer: Akorn, Inc.
Manufactured In: United States
Units Affected: 60,176 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.